COPE for Children With Asthma: Intervention for Children With Asthma
Childhood Asthma, Childhood Anxiety Disorder, Childhood Depression

About this trial
This is an interventional basic science trial for Childhood Asthma focused on measuring Childhood Asthma, Childhood Anxiety, Childhood Depression, Childhood Quality of Life
Eligibility Criteria
Inclusion Criteria:
- Children age 8-12 years enrolled in Columbus City Schools
- Diagnosis of persistent asthma requiring daily inhaled controller medication use at some point (medical condition form on file with the school/CG report)
- Have symptoms depression or anxiety per the PROMIS/SCARED measures
- Have written consent to participate provided by care giver and child assent
- The participating care giver has primary or at least equal responsibility for the day-to-day management of the child's asthma
- care givers provide written consent for their own participation
- Be able to speak, read, and write in English (care giver and child).
Exclusion Criteria:
- has other significant pulmonary conditions (e.g., pulmonary fibrosis, cystic fibrosis)
- currently receiving treatment from a mental health professional
- child or CG has cognitive learning disability that could interfere with the ability to comprehend the interview questions.
Sites / Locations
- Columbus City Schools
Arms of the Study
Arm 1
Experimental
Intervention
This pre-experimental pilot project is a single group, pretest-posttest design with a 6-week post-intervention follow-up. A single group design was chosen for this feasibility pilot study because the COPE for Asthma intervention is newly adapted for 8 to 12-year-old children with asthma in an urban setting. The intervention will consist of 7 weekly sessions (30 minutes each). COPE for Asthma is a manualized, cognitive behavior skills-building intervention to improve the physical and mental health outcomes of children with asthma and elevated symptoms of anxiety or depression. Surveys with children and their parents/caregivers (CGs) will occur at baseline, immediately post-intervention and 6 weeks' post-intervention.